August 9, 2012 — The U.S. Food and Drug Administration (FDA) is informing healthcare providers and patients that the ...
Stents
This channel includes news and new technology innovations for stents, also called vascular scaffolds. Stents are used to help prop open a vessel treated by balloon angioplasty because of the barotrauma caused by the extreme stretching of vessel walls. The stent enables to vessel to heal in an open position with collapsing. Drug eluting stents (DES) are coated in anti-proliferative drugs to precent scar tissue growth which can cause restenosis and occlude the vessel. DES require antiplatelet therapy because the drug carrier polymer on DES can cause thrombus inside the stent, even years after treatment, which is why bare metal stents are still used in some patients. This page includes news on coronary stents, carotid stents, peripheral stents, bioresorbable stents, and renal stents.
July 17, 2012 — Arterial Remodeling Technologies (ART) reported that they have achieved a medical milestone with its ...
As the average age of the U.S. population and the number of patients at high risk for cardiovascular disease ...
While the current positive revolution in percutaneous coronary intervention (PCI) practice has been made possible by the ...
July 16, 2012 — Reva Medical Inc. announced it completed clinical enrollment with the ReZolve drug-eluting bioresorbable ...
June 21, 2012 — Plans for a new study involving BioFreedom, the polymer-free drug-coated stent (DCS) from Biosensors ...
June 15, 2012 — Stentys SA, a medical technology company commercializing the world's first and only self-apposing stent ...
Evaluating the performance of your cath lab is key to developing a strategic plan for improving service offerings ...
June 4, 2012 — Boston Scientific Corp. has received U.S. Food and Drug Administration (FDA) regulatory approval of 32 mm ...
May 30, 2012 — Tryton Medical Inc., the leading developer of stents designed to definitively treat bifurcation lesions ...
May 30, 2012 - According to study results to be featured in the late-breaking clinical trials session at the American ...
May 23, 2012 — Boston Scientific Corp. announces that the Synergy everolimus-eluting bioabsorbable polymer-coated ...
May 23, 2012 — Boston Scientific Corp. announced two-year results from the PLATINUM Small Vessel study, demonstrating ...
May 22, 2012 — New long-term data from the DIVERGE study presented at EuroPCR 2012 showed that the use of the Axxess dru ...
May 15, 2012 –– As EuroPCR 2012 gets underway, Medtronic Inc.announced that the Resolute Integrity Coronary Stent System ...
May 15, 2012 — A simple clinical assessment performed in the doctor’s office can identify patients who are at high risk ...
August 09, 2012